EX-99.A 2 d310633dex99a.htm EX-99.A EX-99.A

Exhibit A

AGREEMENT

The undersigned agree that this Amendment No. 2 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of Catalyst Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.

 

Armistice Capital, LLC
By:  

/s/ Steven Boyd

Steven Boyd
Managing Member

/s/ Steven Boyd

Steven Boyd